METiS Pharmaceuticals to Present Liver-Targeted mRNA Delivery Innovation at SITC 2024

Nov 06, 2024 10:42 CST Updated 10:42

METiS TechBio

AI-Driven Drug Formulation Developer

METiS TechBio will attend the event held in Houston, Texas, USA from November 6-10.The 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)Above, in the form of a posterShowcase Innovative Research Achievements in Liver-Targeted Delivery Technology.

Poster Information

Report Title:Organ-Specific Delivery of a mRNA-Encoded Bispecific T Cell Engager Targeting Glypican-3 in Hepatocellular Carcinoma

Presentation Session 1：Immune Engineering Workshop Session IV: Poster Session

Location: George R. Brown Convention Center – Level 3 – Grand Ballroom A

Time: Thursday, Nov. 7 at 3:10–5 p.m.

Number: 1342

Session Two: Annual Meeting Poster Presentations

Location:George R. Brown Convention Center – Level 1 – Exhibit Halls AB

Time: Saturday, Nov. 9 from 12:15–6:30 p.m.

Number: 1342

Click

Read the Original Text

Visit the official website for more details about the conference.

Learn More About METiS TechBio

Related Reading:

METiS TechBio Scientist Discusses miRNA, RNAi, and mRNA Technologies

From AI Dominating the Nobel Prize to Industry Trends: METiS TechBio's Insights and Forecasts

"White Paper on Drug Delivery" Officially Released (with 112-page PDF download)

30 Academicians and the 38 Pharmaceutical Innovation Companies They Co-founded